AI assistant
Solana Co — Director's Dealing 2015
May 14, 2015
32724_dirs_2015-05-14_00a60106-fb9e-4c3a-abd2-614b2101c70d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2015-05-14
Reporting Person: Kaczmarek Kurt (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Common Stock, Without Par Value | 16035026 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $.50 | 2019-06-18 | Class A Common Stock (400000) | Direct |
Footnotes
F1: Represents shares directly held by Advanced NeuroRehabilitation, LLC ("ANR"). The Reporting Person is the managing member of ANR. The Reporting Person disclaims pecuniary interest in the reported securities except to the extent of his economic interest.
F2: One-third of the shares subject to this option vested on June 19, 2014 and the remaining shares will vest in equal amounts on each of June 19, 2015 and June 19, 2016.
F3: Translated into U.S. dollars from Canadian dollars based on the noon buying rate from the Federal Reserve Bank of USD$1.00 = CAD$1.2086 on May 8, 2015, based on an option exercise price of CAD$0.60.